000788 北大医药
交易中 11-20 10:51:09
资讯
新帖
简况
股市必读:北大医药新发布《关于公司董事长兼总裁及部分非独立董事离任的公告》
证券之星 · 11-16
股市必读:北大医药新发布《关于公司董事长兼总裁及部分非独立董事离任的公告》
北大医药(000788)披露公司董事长兼总裁及部分非独立董事离任的公告,11月12日股价下跌0.18%
证券之星 · 11-12
北大医药(000788)披露公司董事长兼总裁及部分非独立董事离任的公告,11月12日股价下跌0.18%
北大医药四名董事集体离职
东方财富网 · 11-12
北大医药四名董事集体离职
北大医药最新公告:董事长兼总裁及部分非独立董事离任
证券之星 · 11-12
北大医药最新公告:董事长兼总裁及部分非独立董事离任
股市必读:11月10日北大医药发布公告,股东减持174.25万股
证券之星 · 11-11
股市必读:11月10日北大医药发布公告,股东减持174.25万股
北大医药(000788)11月2日主力资金净卖出216.91万元
证券之星 · 11-02
北大医药(000788)11月2日主力资金净卖出216.91万元
骨科大佬“1元”接盘北大医药,徐晰人退场
市场资讯 · 10-30
骨科大佬“1元”接盘北大医药,徐晰人退场
北大医药(000788)2026年三季报简析:净利润同比下降45.72%,三费占比上升明显
证券之星 · 10-28
北大医药(000788)2026年三季报简析:净利润同比下降45.72%,三费占比上升明显
北大医药(000788)10月28日主力资金净卖出43.87万元
证券之星 · 10-28
北大医药(000788)10月28日主力资金净卖出43.87万元
北大医药(000788)9月30日股东户数5.44万户,较上期减少5%
证券之星 · 10-27
北大医药(000788)9月30日股东户数5.44万户,较上期减少5%
图解北大医药三季报:第三季度单季净利润同比下降49.16%
证券之星 · 10-27
图解北大医药三季报:第三季度单季净利润同比下降49.16%
北大医药最新公告:控股股东上层股权结构变更实际控制人变更为程栋
证券之星 · 10-26
北大医药最新公告:控股股东上层股权结构变更实际控制人变更为程栋
北大医药(000788)披露持股5%以上股东部分股份被司法处置的预披露公告,10月22日股价下跌2.73%
证券之星 · 10-22
北大医药(000788)披露持股5%以上股东部分股份被司法处置的预披露公告,10月22日股价下跌2.73%
北大医药(000788)10月21日主力资金净买入6143.97万元
证券之星 · 10-21
北大医药(000788)10月21日主力资金净买入6143.97万元
异动快报:北大医药(000788)10月21日13点6分触及涨停板
证券之星 · 10-21
异动快报:北大医药(000788)10月21日13点6分触及涨停板
股市必读:北大医药新发布《关于获得《药品注册证书》的公告》
证券之星 · 10-21
股市必读:北大医药新发布《关于获得《药品注册证书》的公告》
股市必读:10月16日北大医药发布公告,股东减持596.6万股
证券之星 · 10-19
股市必读:10月16日北大医药发布公告,股东减持596.6万股
北大医药(000788)披露持股5%以上股东部分股份被司法强制执行的进展暨触及1%整数倍的公告,10月16日股价下跌1.1%
证券之星 · 10-16
北大医药(000788)披露持股5%以上股东部分股份被司法强制执行的进展暨触及1%整数倍的公告,10月16日股价下跌1.1%
股市必读:10月14日北大医药发生1笔大宗交易 成交金额2429.68万元
证券之星 · 10-15
股市必读:10月14日北大医药发生1笔大宗交易 成交金额2429.68万元
股市必读:10月9日北大医药现1笔折价13.05%的大宗交易 合计成交367.78万元
证券之星 · 10-12
股市必读:10月9日北大医药现1笔折价13.05%的大宗交易 合计成交367.78万元
加载更多
公司概况
公司名称:
北大医药股份有限公司
所属行业:
医药制造业
上市日期:
1997-06-16
主营业务:
北大医药股份有限公司的主营业务是化学药品制剂的研发、生产和销售,医药流通以及医疗服务等业务。公司的主要产品是注射用头孢曲松钠、注射用美罗培南、注射用头孢米诺钠、盐酸莫西沙星注射液、盐酸克林霉素棕榈酸酯颗粒、萘丁美酮胶囊、塞来昔布胶囊、右酮洛芬片、右酮洛芬胶囊、盐酸丁螺环酮片、奥氮平片。公司是国家创新型试点企业、国家火炬计划重点高新技术企业、国家两化融合贯标示范企业、重庆市技术创新示范企业、重庆市专精特新企业、重庆市制造业百强企业。
发行价格:
5.70
{"stockData":{"symbol":"000788","market":"SZ","secType":"STK","nameCN":"北大医药","latestPrice":4.66,"timestamp":1795143069000,"preClose":4.82,"halted":0,"volume":6956774,"delay":0,"changeRate":-0.0332,"floatShares":596000000,"shares":596000000,"eps":0.0348,"marketStatus":"交易中","change":-0.16,"latestTime":"11-20 10:51:09","open":4.71,"high":4.73,"low":4.52,"amount":32040400,"amplitude":0.0436,"askPrice":4.66,"askSize":69,"bidPrice":4.65,"bidSize":444,"shortable":0,"etf":0,"ttmEps":0.0348,"tradingStatus":2,"nextMarketStatus":{"tag":"午间休市","tradingStatus":4,"beginTime":1795145400000},"marketStatusCode":2,"adr":0,"adjPreClose":4.82,"symbolType":"stock","openAndCloseTimeList":[[1795138200000,1795145400000],[1795150800000,1795158000000]],"highLimit":5.3,"lowLimit":4.34,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":595987425,"isCdr":false,"pbRate":1.89,"roa":"--","peRate":133.908046,"roe":"4.89%","epsLYR":0.1391,"committee":0.297133,"marketValue":2777000000,"turnoverRate":0.0117,"status":1,"floatMarketCap":2777000000},"requestUrl":"/m/hq/s/000788","defaultTab":"news","newsList":[{"id":"2683657309","title":"股市必读:北大医药新发布《关于公司董事长兼总裁及部分非独立董事离任的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2683657309","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2683657309?lang=zh_cn&edition=full","pubTime":"2026-11-16 02:25","pubTimestamp":1794767115,"startTime":"0","endTime":"0","summary":"公司公告汇总关于公司董事长兼总裁及部分非独立董事离任的公告北大医药股份有限公司董事会于近日收到董事长兼总裁徐晰人、非独立董事陈岳忠、包铁民、黄联军的书面辞职报告。公司将尽快完成非独立董事补选工作。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026111600000824.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0012","BK0028","BK0096","BK0102","BK0239","BK0122","000788","BK0060"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682355597","title":"北大医药(000788)披露公司董事长兼总裁及部分非独立董事离任的公告,11月12日股价下跌0.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2682355597","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2682355597?lang=zh_cn&edition=full","pubTime":"2026-11-12 22:23","pubTimestamp":1794493398,"startTime":"0","endTime":"0","summary":"截至2026年11月12日收盘,北大医药报收于5.5元,较前一交易日下跌0.18%,最新总市值为32.78亿元。近日,北大医药股份有限公司发布《关于公司董事长兼总裁及部分非独立董事离任的公告》。公告显示,公司董事会于近日收到董事长兼总裁徐晰人先生、非独立董事陈岳忠先生、包铁民先生、黄联军先生的书面辞职报告。陈岳忠先生因个人原因辞去非独立董事及董事会战略委员会委员职务,辞任后仍在公司任职。公司将尽快完成非独立董事补选工作。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026111200042351.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000788","BK0012","BK0122","BK0060","BK0028","BK0239","BK0096","BK0102"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682594299","title":"北大医药四名董事集体离职","url":"https://stock-news.laohu8.com/highlight/detail?id=2682594299","media":"东方财富网","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2682594299?lang=zh_cn&edition=full","pubTime":"2026-11-12 21:15","pubTimestamp":1794489327,"startTime":"0","endTime":"0","summary":"【导读】北大医药四名董事集体离职“北大”招牌进入倒计时中国基金报记者刘墨11月12日晚间,北大医药(000788)发布《关于公司董事长兼总裁及部分非独立董事离任的公告》,董事长兼总裁徐晰人及陈岳忠、包铁民、黄联军三名非独立董事同时提交书面辞职报告,理由均为“个人原因”。这场看似突然的集体离职,实为一段延续22个月的控制权更迭的收尾。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"east_money_stock","url":"http://finance.eastmoney.com/news/1354,202611123929896465.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/news/1354,202611123929896465.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"east_money_stock","symbols":["BK0012","BK0028","000788","BK0060","BK0239","BK0122","BK0102","BK0096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682661635","title":"北大医药最新公告:董事长兼总裁及部分非独立董事离任","url":"https://stock-news.laohu8.com/highlight/detail?id=2682661635","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2682661635?lang=zh_cn&edition=full","pubTime":"2026-11-12 17:32","pubTimestamp":1794475927,"startTime":"0","endTime":"0","summary":"北大医药(000788.SZ)公告称,公司董事会收到董事长兼总裁徐晰人、非独立董事陈岳忠、包铁民、黄联军的书面辞职报告。徐晰人因个人原因辞去董事长、非独立董事、总裁等职务,且不再担任公司任何职务;陈岳忠辞去非独立董事职务,辞职后仍在公司任职;包铁民、黄联军辞去非独立董事职务,且不再担任公司任何职务。上述辞职不会导致董事会成员低于法定最低人数,不影响公司正常经营,公司将尽快完成非独立董事补选工作。以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026111200031108.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0102","BK0239","BK0028","BK0096","000788","BK0012","BK0122","BK0060"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682231020","title":"股市必读:11月10日北大医药发布公告,股东减持174.25万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2682231020","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2682231020?lang=zh_cn&edition=full","pubTime":"2026-11-11 02:53","pubTimestamp":1794336791,"startTime":"0","endTime":"0","summary":"股本股东变化:西南合成医药集团有限公司于11月3日至9日减持174.25万股,占总股本0.2924%。股本股东变化股东增减持11月10日北大医药发布公告《北大医药:关于持股5%以上股东持股变动触及1%整数倍的公告》,其股东西南合成医药集团有限公司于2026年11月3日至2026年11月9日间合计减持174.25万股,占公司目前总股本的0.2924%,变动期间该股股价上涨2.43%,截止11月9日收盘报5.49元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026111100006150.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0102","BK0122","BK0096","BK0028","BK0239","000788","BK0060","BK0012"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680397457","title":"北大医药(000788)11月2日主力资金净卖出216.91万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2680397457","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680397457?lang=zh_cn&edition=full","pubTime":"2026-11-02 15:41","pubTimestamp":1793605312,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2026年11月2日收盘,北大医药报收于5.36元,上涨6.35%,换手率5.91%,成交量35.19万手,成交额1.83亿元。11月2日的资金流向数据方面,主力资金净流出216.91万元,占总成交额1.19%,游资资金净流入174.27万元,占总成交额0.95%,散户资金净流入42.64万元,占总成交额0.23%。北大医药主营业务:化学药品制剂的研发、生产和销售,医药流通以及医疗服务等业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110200017720.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0122","BK0239","BK0012","BK0028","BK0102","BK0096","BK0060","000788"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679295236","title":"骨科大佬“1元”接盘北大医药,徐晰人退场","url":"https://stock-news.laohu8.com/highlight/detail?id=2679295236","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679295236?lang=zh_cn&edition=full","pubTime":"2026-10-30 16:48","pubTimestamp":1793350080,"startTime":"0","endTime":"0","summary":"“1元”交接之外,旧股东的债务尚待处理,大客户留下的收入缺口仍在。截至10月30日收盘,北大医药股价为5.04元,总市值约30亿元。“1元”再度易主徐晰人交出控制权公告显示,此次转让的标的是合成集团100%股权。入主北大医药后,他于2025年4月被选为董事长,同年7月获聘总裁。“骨科大佬”接盘医院资源能否撑起药企业绩处理一家企业的旧问题,对程栋而言并非全然陌生。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/s/2026-10-30/doc-iniwywtv8237543.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0122","BK0060","BK0239","BK0096","000788","BK0012","BK0028","BK0102"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678395460","title":"北大医药(000788)2026年三季报简析:净利润同比下降45.72%,三费占比上升明显","url":"https://stock-news.laohu8.com/highlight/detail?id=2678395460","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678395460?lang=zh_cn&edition=full","pubTime":"2026-10-28 20:21","pubTimestamp":1793190060,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理,近期北大医药发布2026年三季报。截至本报告期末,公司营业总收入6.52亿元,同比下降47.01%,归母净利润7381.47万元,同比下降45.72%。按单季度数据看,第三季度营业总收入2.05亿元,同比下降25.04%,第三季度归母净利润1814.39万元,同比下降49.16%。本报告期北大医药三费占比上升明显,财务费用、销售费用和管理费用总和占总营收同比增幅达30.11%。去年的净利率为5.59%,算上全部成本后,公司产品或服务的附加值一般。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102800047107.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000788"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678645596","title":"北大医药(000788)10月28日主力资金净卖出43.87万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2678645596","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678645596?lang=zh_cn&edition=full","pubTime":"2026-10-28 15:33","pubTimestamp":1793172788,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2026年10月28日收盘,北大医药报收于5.4元,下跌2.88%,换手率7.08%,成交量42.22万手,成交额2.25亿元。10月28日的资金流向数据方面,主力资金净流出43.87万元,占总成交额0.2%,游资资金净流入893.44万元,占总成交额3.97%,散户资金净流出849.57万元,占总成交额3.78%。北大医药主营业务:化学药品制剂的研发、生产和销售,医药流通以及医疗服务等业务。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102800029830.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0122","BK0060","BK0096","000788","BK0012","BK0102","BK0028","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678732871","title":"北大医药(000788)9月30日股东户数5.44万户,较上期减少5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2678732871","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678732871?lang=zh_cn&edition=full","pubTime":"2026-10-27 18:38","pubTimestamp":1793097509,"startTime":"0","endTime":"0","summary":"证券之星消息,近日北大医药披露,截至2026年9月30日公司股东户数为5.44万户,较6月30日减少2860.0户,减幅为5.0%。在化学制药行业个股中,北大医药股东户数高于行业平均水平,截至9月30日,化学制药行业平均股东户数为3.84万户。从股价来看,2026年6月30日至2026年9月30日,北大医药区间涨幅为11.89%,在此期间股东户数减少2860.0户,减幅为5.0%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102700034643.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0102","BK0122","BK0096","BK0028","BK0239","000788","BK0060","BK0012"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678133811","title":"图解北大医药三季报:第三季度单季净利润同比下降49.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2678133811","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678133811?lang=zh_cn&edition=full","pubTime":"2026-10-27 02:05","pubTimestamp":1793037921,"startTime":"0","endTime":"0","summary":"证券之星消息,北大医药2026年三季报显示,前三季度公司主营收入6.52亿元,同比下降47.01%;归母净利润7381.47万元,同比下降45.72%;扣非净利润5825.84万元,同比下降53.8%;其中2026年第三季度,公司单季度主营收入2.05亿元,同比下降25.04%;单季度归母净利润1814.39万元,同比下降49.16%;单季度扣非净利润1493.46万元,同比下降46.55%;负债率22.05%,投资收益1436.33万元,财务费用-469.45万元,毛利率34.13%。财报数据概要请见下图:本文数据来源于北大医药2026年三季报,仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102700003247.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000788"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678160257","title":"北大医药最新公告:控股股东上层股权结构变更实际控制人变更为程栋","url":"https://stock-news.laohu8.com/highlight/detail?id=2678160257","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678160257?lang=zh_cn&edition=full","pubTime":"2026-10-26 19:40","pubTimestamp":1793014817,"startTime":"0","endTime":"0","summary":"北大医药(000788.SZ)公告称,公司控股股东合成集团上层股权结构发生变更,上海弘康通过收购新优势国际持有的合成集团100%股权,间接取得公司控股权。本次权益变动后,公司控股股东仍为合成集团,实际控制人由徐晰人变更为程栋。以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102600031023.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000788","BK0012","BK0122","BK0060","BK0028","BK0239","BK0096","BK0102"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677959668","title":"北大医药(000788)披露持股5%以上股东部分股份被司法处置的预披露公告,10月22日股价下跌2.73%","url":"https://stock-news.laohu8.com/highlight/detail?id=2677959668","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677959668?lang=zh_cn&edition=full","pubTime":"2026-10-22 17:59","pubTimestamp":1792663152,"startTime":"0","endTime":"0","summary":"截至2026年10月22日收盘,北大医药报收于5.7元,较前一交易日下跌2.73%,最新总市值为33.97亿元。公司于近日披露《关于持股5%以上股东部分股份被司法处置的预披露公告》。公告显示,北大医药股份有限公司持股5%以上股东西南合成医药集团有限公司因与中泰证券融资融券交易纠纷,其所持公司部分股份将被山东省济南市中级人民法院司法强制执行。截至2026年10月20日,西南合成持有公司股份109,950,017股,占总股本的18.45%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102200031176.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0102","BK0012","BK0096","000788","BK0122","BK0239","BK0060","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677565625","title":"北大医药(000788)10月21日主力资金净买入6143.97万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2677565625","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677565625?lang=zh_cn&edition=full","pubTime":"2026-10-21 15:27","pubTimestamp":1792567671,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2026年10月21日收盘,北大医药报收于5.86元,上涨9.94%,换手率9.71%,成交量57.9万手,成交额3.31亿元。10月21日的资金流向数据方面,主力资金净流入6143.97万元,占总成交额18.54%,游资资金净流出1386.78万元,占总成交额4.18%,散户资金净流出4757.19万元,占总成交额14.36%。北大医药主营业务:化学药品制剂的研发、生产和销售,医药流通以及医疗服务等业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102100021260.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0122","000788","BK0239","BK0096","BK0012","BK0102","BK0028","BK0060"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677642588","title":"异动快报:北大医药(000788)10月21日13点6分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2677642588","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677642588?lang=zh_cn&edition=full","pubTime":"2026-10-21 13:10","pubTimestamp":1792559437,"startTime":"0","endTime":"0","summary":"证券之星10月21日盘中消息,13点6分北大医药(000788)触及涨停板。其所属行业化学制药目前上涨。领涨股为莱美药业。该股为医药商业,高校系,医药概念热股,当日医药商业概念上涨0.88%,高校系概念上涨0.78%,医药概念上涨0.55%。10月20日的资金流向数据方面,主力资金净流入203.72万元,占总成交额4.91%,游资资金净流出54.39万元,占总成交额1.31%,散户资金净流出149.33万元,占总成交额3.6%。近5日资金流向一览见下表:北大医药主要指标及行业内排名如下:以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102100019151.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0012","BK0028","000788","BK0060","BK0239","BK0122","BK0102","BK0096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677613030","title":"股市必读:北大医药新发布《关于获得《药品注册证书》的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2677613030","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677613030?lang=zh_cn&edition=full","pubTime":"2026-10-21 02:48","pubTimestamp":1792522093,"startTime":"0","endTime":"0","summary":"公司公告汇总:公司收到国家药监局签发的瑞舒伐他汀依折麦布片《药品注册证书》,该药为化学药品4类,用于高胆固醇血症等治疗。大宗交易10月20日北大医药发生1笔大宗交易,折价10.51%,成交金额539.01万元。公司公告汇总关于获得《药品注册证书》的公告北大医药近日收到国家药品监督管理局核准签发的瑞舒伐他汀依折麦布片《药品注册证书》。审批结论为符合药品注册有关要求,批准注册。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102100001908.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0122","000788","BK0239","BK0096","BK0012","BK0102","BK0028","BK0060"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676573303","title":"股市必读:10月16日北大医药发布公告,股东减持596.6万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2676573303","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2676573303?lang=zh_cn&edition=full","pubTime":"2026-10-19 02:49","pubTimestamp":1792349348,"startTime":"0","endTime":"0","summary":"股本股东变化:西南合成医药集团于10月9日至15日被动减持596.6万股,占总股本1.001%,持股比例由20.00%降至19.00%。公司公告汇总关于持股5%以上股东部分股份被司法强制执行的进展暨触及1%整数倍的公告北大医药股份有限公司于2026年10月9日至10月15日,因司法强制执行,股东西南合成医药集团有限公司通过大宗交易被动减持公司股份5,966,000股,占公司总股本的1%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101900000858.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0102","BK0122","BK0096","BK0028","BK0239","000788","BK0060","BK0012"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675518670","title":"北大医药(000788)披露持股5%以上股东部分股份被司法强制执行的进展暨触及1%整数倍的公告,10月16日股价下跌1.1%","url":"https://stock-news.laohu8.com/highlight/detail?id=2675518670","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675518670?lang=zh_cn&edition=full","pubTime":"2026-10-16 22:35","pubTimestamp":1792161316,"startTime":"0","endTime":"0","summary":"截至2026年10月16日收盘,北大医药报收于5.38元,较前一交易日下跌1.1%,最新总市值为32.06亿元。近日,北大医药股份有限公司发布《关于持股5%以上股东部分股份被司法强制执行的进展暨触及1%整数倍的公告》。本次权益变动后,西南合成持有公司股份比例由20.00%降至19.00%。本次司法强制执行尚未履行完毕,公司将继续履行信息披露义务。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101600040611.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0102","BK0060","BK0012","BK0122","BK0239","000788","BK0028","BK0096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675324498","title":"股市必读:10月14日北大医药发生1笔大宗交易 成交金额2429.68万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2675324498","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675324498?lang=zh_cn&edition=full","pubTime":"2026-10-15 03:24","pubTimestamp":1792005887,"startTime":"0","endTime":"0","summary":"截至2026年10月14日收盘,北大医药报收于5.5元,下跌1.43%,换手率1.9%,成交量11.34万手,成交额6286.92万元。当日关注点交易信息汇总:10月14日主力资金净流入72.56万元,游资资金净流入104.98万元,散户资金净流出177.55万元; 交易信息汇总:当日发生1笔大宗交易,成交金额2429.68万元。大宗交易10月14日北大医药发生1笔大宗交易,成交金额2429.68万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101500003593.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000788","BK0122","BK0028","BK0239","BK0096","BK0060","BK0012","BK0102"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674849389","title":"股市必读:10月9日北大医药现1笔折价13.05%的大宗交易 合计成交367.78万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2674849389","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674849389?lang=zh_cn&edition=full","pubTime":"2026-10-12 04:35","pubTimestamp":1791750911,"startTime":"0","endTime":"0","summary":"截至2026年10月9日收盘,北大医药报收于5.67元,上涨3.47%,换手率4.79%,成交量28.57万手,成交额1.6亿元。当日关注点交易信息汇总:10月9日北大医药主力资金净流出138.48万元,占总成交额0.87%; 交易信息汇总:当日发生1笔折价13.05%的大宗交易,合计成交367.78万元。大宗交易10月9日北大医药发生1笔大宗交易,折价率13.05%,成交金额367.78万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101200001485.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0060","000788","BK0096","BK0028","BK0012","BK0102","BK0122"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1795143071959,"stockEarnings":[{"period":"1week","weight":-0.1236},{"period":"1month","weight":-0.0923},{"period":"3month","weight":-0.1407},{"period":"6month","weight":-0.1268},{"period":"1year","weight":-0.2246},{"period":"ytd","weight":-0.1865}],"compareEarnings":[{"period":"1week","weight":-0.0214},{"period":"1month","weight":-0.0422},{"period":"3month","weight":-0.0839},{"period":"6month","weight":-0.1301},{"period":"1year","weight":-0.0935},{"period":"ytd","weight":-0.0986}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"北大医药股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"54370人(较上一季度减少5.00%)","perCapita":"10961股","listingDate":"1997-06-16","address":"重庆市北碚区水土镇方正大道21号","registeredCapital":"59598万元","survey":" 北大医药股份有限公司的主营业务是化学药品制剂的研发、生产和销售,医药流通以及医疗服务等业务。公司的主要产品是注射用头孢曲松钠、注射用美罗培南、注射用头孢米诺钠、盐酸莫西沙星注射液、盐酸克林霉素棕榈酸酯颗粒、萘丁美酮胶囊、塞来昔布胶囊、右酮洛芬片、右酮洛芬胶囊、盐酸丁螺环酮片、奥氮平片。公司是国家创新型试点企业、国家火炬计划重点高新技术企业、国家两化融合贯标示范企业、重庆市技术创新示范企业、重庆市专精特新企业、重庆市制造业百强企业。","listedPrice":5.7},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.54.0","shortVersion":"4.54.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"北大医药(000788)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供北大医药(000788)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"北大医药,000788,北大医药股票,北大医药股票老虎,北大医药股票老虎国际,北大医药行情,北大医药股票行情,北大医药股价,北大医药股市,北大医药股票价格,北大医药股票交易,北大医药股票购买,北大医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"北大医药(000788)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供北大医药(000788)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}